Study of Thymosin Beta 4 in Patients With Venous Stasis Ulcers
RegeneRx Biopharmaceuticals, Inc. · Venous Stasis Ulcers
Phase 2
Completed
72
2010-03
Industry sponsor intelligence
RegeneRx Biopharmaceuticals, Inc.Clinical Pipeline.
Lead-sponsor view of RegeneRx Biopharmaceuticals, Inc.'s indexed peptide studies, development phases, active programs, completed work and recent registry changes.
- Total
- 5
- Recruiting
- 0
- Active
- 0
- Completed
- 2
- Results posted
- 3
- Avg enrollment
- 35
Pipeline overview
Programs by phase and activity.
Velocity
RegeneRx Biopharmaceuticals, Inc. trials by start year
Study start year · indexed snapshot
Development
Trials by phase
5phase labels
Early Phase 10
Phase 11
Phase 24
Phase 30
Phase 40
| Product | Studies | Early / I | Phase II | Phase III | Phase IV | Active |
|---|---|---|---|---|---|---|
| Thymosin Beta-4 → | 5 | 1 | 4 | 0 | 0 | 0 |
Active peptide trials
In motion now.
No studies in this snapshot.
Completed trials
Finished registry records.
NCT IDStudyPhase / statusEnrollmentUpdated
Study of Thymosin Beta 4 in Patients With Pressure Ulcers
RegeneRx Biopharmaceuticals, Inc. · Pressure Ulcers
Phase 2
Completed
72
2010-02
Search sponsor records
All RegeneRx Biopharmaceuticals, Inc. studies.
This page groups studies where RegeneRx Biopharmaceuticals, Inc. is listed as the lead industry sponsor. Collaborator-only records are not included in the count.
5 matching studies
Last registry update first
Recent updates
Latest registry movement.
NCT01311518A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial InfarctionSep 22, 2021NCT00743769A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy VolunteersApr 17, 2017NCT00311766A Phase 2 Study on Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis BullosaMay 12, 2014NCT00832091Study of Thymosin Beta 4 in Patients With Venous Stasis UlcersMar 30, 2010NCT00382174Study of Thymosin Beta 4 in Patients With Pressure UlcersFeb 1, 2010